Product image of Nasasinutab (Xylometazoline Hydrochloride) supplied by GNH India

Nasasinutab

Active Ingredient:
Xylometazoline Hydrochloride
Origin:
EU

Nasasinutab (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasasinutab, is an alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis by constricting swollen nasal blood vessels.

GNH India supplies Nasasinutab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality manufacturing and regulatory compliance across global markets.

Manufacturer / TM Owner

Kenvue Belgium Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Xylometazoline Hydrochloride is a topical nasal decongestant that reduces mucosal swelling in upper‑respiratory conditions.

  • Common cold: alleviates nasal congestion by shrinking swollen nasal passages.
  • Sinusitis: reduces nasal blockage, improving sinus drainage.
  • Allergic rhinitis: eases congestion caused by allergic inflammation.

How It Works

  • Xylometazoline Hydrochloride acts as a selective alpha‑adrenergic receptor agonist on the vascular smooth muscle of the nasal mucosa. Activation of these receptors induces vasoconstriction, which decreases blood flow, reduces mucosal edema, and opens the nasal airway, thereby relieving congestion.

Side Effects

Adverse reactions are generally mild and related to local nasal irritation.

Common Side Effects

  • Burning sensation in the nose
  • Nasal dryness or crusting
  • Sneezing or mild irritation
  • Headache
  • Altered taste perception
  • Mild epistaxis (nosebleed)

Serious or Rare Side Effects

  • Severe hypertension or cardiovascular strain
  • Rebound nasal congestion with prolonged use
  • Nasal ulceration or septal perforation
  • Allergic reaction (rash, swelling, difficulty breathing)
  • Cardiac arrhythmia
  • Persistent nasal bleeding

Precautions & Warnings

Use Nasasinutab according to label instructions and avoid exceeding recommended duration.

  • Duration limit: Do not use for more than 3‑5 consecutive days to prevent rebound congestion.
  • Age restriction: Not recommended for children under 6 years unless directed by a healthcare professional.
  • Cardiovascular caution: Avoid in patients with uncontrolled hypertension or severe heart disease.
  • Drug interactions: Use cautiously with other nasal decongestants or systemic sympathomimetics.
  • Pregnancy and lactation: Consult a physician before use, as safety data are limited.
  • Store at room temperature: Keep in the original container, protect from moisture and direct heat.

Avoid Interactions

Xylometazoline may interact with other agents that affect vascular tone or blood pressure. Major Interactions (Avoid):\n- Concurrent use of other nasal decongestants: risk of excessive vasoconstriction and hypertension.

  • Systemic sympathomimetic drugs (e.g., pseudoephedrine): may amplify cardiovascular effects.
  • Monoamine oxidase inhibitors (MAOIs): potential for hypertensive crisis.

Moderate Interactions (Monitor Closely)

  • Antihypertensive medications: may reduce their efficacy.
  • Antidepressants (SSRIs, SNRIs): monitor for increased blood pressure.
  • Beta‑blockers: possible attenuation of decongestant effect.
  • Herbal stimulants (e.g., ephedra): watch for additive sympathomimetic activity.

Frequently Asked Questions

Nasasinutab contains Xylometazoline Hydrochloride, an over‑the‑counter nasal decongestant used to relieve nasal blockage caused by the common cold, sinusitis, and allergic rhinitis. It works locally in the nose to reduce swelling of the nasal mucosa, improving airflow.

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa, it stimulates alpha‑adrenergic receptors on blood vessels, causing vasoconstriction. This reduces blood flow to the swollen tissue, decreasing edema and opening the nasal passages.

The appropriate dose of Nasasinutab is determined by the prescribing healthcare professional. Typically, a few sprays per nostril are used, but the exact amount and frequency should follow the label instructions or the prescriber’s guidance.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Nasasinutab to weigh potential benefits against any unknown risks.

To order Nasasinutab, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nasasinutab’s active ingredient, Xylometazoline Hydrochloride, offers rapid onset of action and is commonly used in Europe. Compared with older agents like phenylephrine, Xylometazoline provides longer duration of relief with a lower incidence of systemic side effects, though all nasal decongestants share a risk of rebound congestion with prolonged use.

Nasasinutab should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Do not use the product if the seal is broken or the spray appears discolored.

Nasasinutab is administered intranasally as a spray. The user tilts the head slightly forward, inserts the nozzle into one nostril, and delivers the prescribed number of sprays while breathing in gently. The same procedure is repeated in the other nostril if required.

Serious risks, though rare, include severe hypertension, cardiac arrhythmias, rebound nasal congestion after prolonged use, nasal ulceration or septal perforation, and allergic reactions such as rash, swelling, or difficulty breathing. Any of these symptoms should prompt immediate medical attention.

Nasasinutab should be avoided by individuals with known hypersensitivity to Xylometazoline or any formulation components, patients with uncontrolled hypertension or severe cardiovascular disease, children under the age recommended on the label, and anyone currently using other nasal decongestants without medical advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Xylometazoline Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT